Clinical Trials for Spinogenix

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Spinogenix

Clinical Trials (4)

NCT06903286
Extension Study of Participants From SPG302-ALS-001
PHASE2Enrolling by invitation
16 participants
Started: May 29, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor3 locations
NCT06833281
Extension Study of Participants From SPG302-ALZ-101
PHASE2Enrolling by invitation
24 participants
Started: Mar 25, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT06442462
Study of SPG302 in Adults With Schizophrenia
PHASE2Recruiting
32 participants
Started: Aug 1, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor3 locations
NCT06427668
Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)
PHASE2Active, not recruiting
24 participants
Started: Jul 29, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations